VRTX - Vertex Pharmaceuticals Inc / Ma - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VRTX (875320)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2024-02-14
VRTXLeiden Jeffrey MExec COBS - Sale$419.10-9,01118,336-33%-$3,776,528
M
2024-02-12
VRTXLeiden Jeffrey MExec COBS - Sale$419.42-3,39327,347-11%-$1,423,104
2024-02-12
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$420.24-3,22281,811-4%-$1,354,013
2024-02-12
VRTXBiller JonathanEVP, GCS - Sale$418.77-1,73818,280-9%-$727,822
2024-02-12
VRTXAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$420.24-91323,137-4%-$383,679
2024-02-12
VRTXArbuckle Stuart AEVP, COOS - Sale$420.24-4,29575,858-5%-$1,804,931
2024-02-12
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$420.24-1,3749,676-12%-$577,410
2024-02-12
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$420.24-3,14547,588-6%-$1,321,655
2024-01-08
VRTXLeiden Jeffrey MExec COBS - Sale$419.07-6,6482,863-70%-$2,785,977
2024-01-02
VRTXWagner Charles F JrEVP, CFOS - Sale$405.00-3,00043,693-6%-$1,215,000
D
2023-12-15
VRTXKewalramani ReshmaCEO, PresS - Sale+OE$407.00-17,135108,711-14%-$6,973,945
2023-12-13
VRTXLeiden Jeffrey MExec COBS - Sale$399.42-13,3549,511-58%-$5,333,799
2023-12-13
VRTXKewalramani ReshmaCEO, PresS - Sale$397.00-5,098108,711-4%-$2,023,906
D
2023-12-13
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$399.00-8,60356,696-13%-$3,432,597
2023-11-20
VRTXWagner Charles F JrEVP, CFOS - Sale$349.88-3,00046,693-6%-$1,049,640
2023-11-15
VRTXSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$369.92-3566,2610%-$12,947
2023-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$369.92-1932,0380%-$7,028
2023-11-14
VRTXBozic CarmenEVP, CMOS - Sale$380.82-5,65029,302-16%-$2,151,633
2023-11-13
VRTXKewalramani ReshmaCEO, PresS - Sale$377.00-5,097113,809-4%-$1,921,569
D
2023-11-06
VRTXSachs Bruce IDirS - Sale+OE$385.00-11,25040,000-22%-$4,331,250
2023-10-31
VRTXBozic CarmenEVP, CMOS - Sale$355.92-5,65134,952-14%-$2,011,304
2023-10-17
VRTXBozic CarmenEVP, CMOS - Sale$373.25-5,65140,603-12%-$2,109,236
2023-10-17
VRTXBhatia Sangeeta N.DirS - Sale$375.00-2433,901-6%-$91,125
2023-10-16
VRTXLeiden Jeffrey MExec COBS - Sale$374.00-12,96222,865-36%-$4,847,788
2023-10-06
VRTXBhatia Sangeeta N.DirS - Sale$360.00-2424,144-6%-$87,120
2023-10-03
VRTXBozic CarmenEVP, CMOS - Sale$345.28-5,65146,254-11%-$1,951,177
2023-10-02
VRTXBiller JonathanEVP, GCS - Sale$346.76-61010,569-5%-$211,524
2023-09-19
VRTXBozic CarmenEVP, CMOS - Sale$351.00-5,65151,905-10%-$1,983,501
2023-09-05
VRTXBozic CarmenEVP, CMOS - Sale$352.66-5,65157,556-9%-$1,992,882
2023-08-23
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$355.00-2,50048,637-5%-$887,500
D
2023-08-10
VRTXKearney Terrence CDirS - Sale+OE$350.00-10,0006,536-60%-$3,500,000
2023-08-10
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$345.79-5,75051,137-10%-$1,988,293
2023-08-10
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$350.00-10,03166,261-13%-$3,510,850
2023-08-09
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$345.51-6332,0380%-$21,767
2023-08-09
VRTXBhatia Sangeeta N.DirS - Sale$345.51-2424,386-5%-$83,613
D
2023-07-17
VRTXSachs Bruce IDirS - Sale+OE$356.75-11,25040,000-22%-$4,013,459
2023-07-17
VRTXKewalramani ReshmaCEO, PresS - Sale$355.00-7,828118,906-6%-$2,778,940
D
2023-06-15
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$349.00-8,60356,696-13%-$3,002,447
2023-05-30
VRTXArbuckle Stuart AEVP, COOS - Sale$329.82-8256,6960%-$27,045
2023-05-30
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$329.82-2896,838-4%-$95,318
M
2023-05-05
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.00-3,27232,038-9%-$1,145,213
M
2023-05-05
VRTXLeiden Jeffrey MExec COBS - Sale$349.25-2,00435,827-5%-$699,887
M
2023-05-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$350.71-4,40335,310-11%-$1,544,187
M
2023-05-02
VRTXLeiden Jeffrey MExec COBS - Sale$349.98-10,95837,831-22%-$3,835,062
2023-05-02
VRTXBhatia Sangeeta N.DirS - Sale$348.28-5804,628-11%-$202,004
2023-04-27
VRTXKewalramani ReshmaCEO, PresS - Sale$339.08-3,317126,652-3%-$1,124,726
2023-04-12
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$326.70-7,56739,713-16%-$2,472,164
D
2023-04-12
VRTXSachs Bruce IDirS - Sale+OE$326.73-21,30040,000-35%-$6,959,422
2023-04-04
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$315.81-52247,280-1%-$164,854
2023-03-24
VRTXWagner Charles F JrEVP, CFOS - Sale$305.38-1,76849,611-3%-$539,912
2023-03-17
VRTXWagner Charles F JrEVP, CFOS - Sale$296.39-2,00051,379-4%-$592,786
2023-03-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.59-2,74649,268-5%-$825,423
M
2023-03-10
VRTXWagner Charles F JrEVP, CFOS - Sale$291.98-4,75453,379-8%-$1,388,054
2023-02-27
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$287.48-35456,805-1%-$101,768
2023-02-27
VRTXArbuckle Stuart AEVP, COOS - Sale$287.47-5,03456,696-8%-$1,447,143
2023-02-27
VRTXAmbrose KristenSVP, Chief Accounting OfficerS - Sale$287.55-1,2077,303-14%-$347,072
2023-02-27
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$287.51-4,23832,038-12%-$1,218,449
2023-02-22
VRTXArbuckle Stuart AEVP, COOS - Sale$294.33-2,40166,444-3%-$706,679
2023-02-21
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$293.75-48060,467-1%-$141,002
2023-02-21
VRTXArbuckle Stuart AEVP, COOS - Sale$293.75-2,40268,845-3%-$705,596
2023-02-21
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$293.77-4,00240,246-9%-$1,175,676
2023-02-14
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.52-32065,4450%-$95,527
2023-02-14
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.40-2,18159,734-4%-$655,161
2023-02-14
VRTXArbuckle Stuart AEVP, COOS - Sale$298.68-6,39875,745-8%-$1,910,962
2023-02-14
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.70-6,39847,998-12%-$1,911,108
2023-02-13
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.99-27565,7650%-$82,223
2023-02-13
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.39-11361,9150%-$33,944
2023-02-13
VRTXArbuckle Stuart AEVP, COOS - Sale$298.92-4,88782,143-6%-$1,460,816
2023-02-13
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$298.90-4,79854,396-8%-$1,434,126
D
2023-02-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$306.00-1,30468,645-2%-$399,022
2023-01-31
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$325.00-10637,9980%-$34,450
D
2023-01-31
VRTXSachs Bruce IDirS - Sale+OE$325.01-1,20041,210-3%-$390,012
2023-01-30
VRTXCarney LloydDirS - Sale$320.52-2,7004,150-39%-$865,406
D
2023-01-27
VRTXLee YuchunDirS - Sale+OE$322.03-1,4291,875-43%-$460,177
DM
2023-01-25
VRTXLee YuchunDirS - Sale+OE$316.15-8,0001,875-81%-$2,529,174
2023-01-25
VRTXKewalramani ReshmaCEO, PresS - Sale$315.05-10,00089,598-10%-$3,150,500
DM
2023-01-23
VRTXLee YuchunDirS - Sale+OE$312.46-6,1291,875-77%-$1,915,044
DM
2023-01-17
VRTXLee YuchunDirS - Sale+OE$312.04-4,4421,875-70%-$1,386,099
2022-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$308.61-3436,0770%-$10,493
D
2022-11-07
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$303.04-1,30336,077-3%-$394,859
2022-11-02
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$312.64-32038,104-1%-$100,045
2022-10-24
VRTXBhatia Sangeeta N.DirS - Sale$310.00-6214,040-13%-$192,510
2022-10-18
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$300.31-1,79139,192-4%-$537,860
2022-08-15
VRTXKewalramani ReshmaCEO, PresS - Sale$305.06-11,68999,598-11%-$3,565,846
D
2022-08-15
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$303.93-22,17345,418-33%-$6,738,991
2022-08-15
VRTXLiu JoySVP, GCS - Sale$303.90-3,7479,605-28%-$1,138,723
D
2022-08-10
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$300.41-18061,0200%-$54,073
2022-08-10
VRTXLiu JoySVP, GCS - Sale$300.32-3613,3520%-$10,812
2022-08-08
VRTXBhatia Sangeeta N.DirS - Sale$293.03-6214,661-12%-$181,972
2022-08-09
VRTXLiu JoySVP, GCS - Sale$300.00-94613,388-7%-$283,800
2022-08-09
VRTXTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$298.97-1,40046,090-3%-$418,557
D
2022-08-09
VRTXArbuckle Stuart AEVP, COOS - Sale+OE$300.67-5,69061,136-9%-$1,710,817
D
2022-08-08
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$292.54-1,30436,077-3%-$381,469
2022-07-29
VRTXBhatia Sangeeta N.DirS - Sale$278.77-6215,282-11%-$173,116
D
2022-07-25
VRTXLeiden Jeffrey MExec COBS - Sale+OE$281.38-132,0792,863-98%-$37,164,481
D
2022-07-19
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$288.65-17,86536,077-33%-$5,156,730
2022-06-24
VRTXKewalramani ReshmaCEO, PresS - Sale$291.30-11,689111,153-10%-$3,405,006
2022-05-16
VRTXSanna BastianoEVP, Cell, Genetic TherapiesS - Sale$252.83-4541,7490%-$11,377
2022-05-16
VRTXArbuckle Stuart AEVP, COOS - Sale$251.19-13364,9000%-$33,408
2022-05-16
VRTXLiu JoySVP, GCS - Sale$252.88-13314,334-1%-$33,633

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top